Human Regenerative Technologies


Provider and developer of human amniotic- and placental-derived tissue allografts and preservation technologies. Operates under U.S. HCT/P regulations and holds accreditation and multiple state, federal, and Canadian registrations. Focus areas include development and processing of placental and amniotic tissue for clinical use, tissue preservation R&D, and accredited tissue bank operations.

Industries

biotechnology
health-care
health-diagnostics

Nr. of Employees

small (1-50)

Human Regenerative Technologies

El Segundo, California, United States, North America


Products

Thin Amniotic Membrane

A single-layer, dehydrated amnion membrane allograft, with an intact, devitalized epithelial layer designed for maximum ease and versatility.

Thick Amniotic Membrane

A chorion-based dehydrated amniotic membrane allograft, with intact, devitalized cellular components that is thicker and easier to handle and apply.

WoundFix™

Dehydrated amniotic membrane tissue allograft intended for homologous use as a wound covering in the management of acute and chronic wounds.

WoundPlus™

Dehydrated amniotic membrane tissue allograft, intended for homologous use as a wound covering in the management of acute and chronic wounds, featuring a natural rippled surface for improved self-adherence.

E-Graft™

Dehydrated amniotic membrane tissue allograft, intended for homologous use as a wound covering in the management of acute and chronic wounds, featuring a natural macro-texture surface.

HydraTek

Revolutionary technology and sophisticated processing methods that capitalize on the full natural potential of the placenta for tissue allografts, preserving function and integrity in their natural hydrated state.


Services

Processing and preparation of human amniotic membrane and placental connective tissue allografts for clinical distribution, aligned with accreditation and HCT/P regulatory requirements.

Expertise Areas

  • Tissue banking and allograft processing
  • Tissue preservation and stabilization
  • Regulatory compliance for HCT/Ps (21 CFR Part 1271, PHS §361)
  • Wound care and orthobiologics
  • Show More (1)

Key Technologies

  • Allograft processing methods for amniotic and placental tissues
  • Tissue preservation technologies for placental-derived materials
  • Tissue banking and distribution systems
  • Regulatory-compliant HCT/P handling and documentation

News & Updates

Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).

Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).

Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).

Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).

Participation in the American College of Foot & Ankle Surgeons meeting.

Participation in the Symposium on Advanced Wound Care.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.